Stimulan
Device Bone Void Filler
General payments
$775,519
Research payments
$0
Through program year 2025, $775,519 in general payments and $0 in research payments were reported against Stimulan (Bone Void Filler).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $176,423 | 1,936 |
| 2024 | General | $137,569 | 1,314 |
| 2023 | General | $99,544 | 509 |
| 2021 | General | $107,783 | 414 |
| 2020 | General | $47,818 | 214 |
| 2019 | General | $206,382 | 691 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 76 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,078 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.